Diabetes Care, Vol 19, Issue 7 751-754, Copyright © 1996 by American Diabetes Association

ARTICLES

The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM

NS Levitt, KB Stansberry, S Wynchank and AI Vinik
University of Cape Town, Groote Schuur Hospital, South Africa.

OBJECTIVE: To test the natural progression of symptoms of autonomic neuropathy (AN) and function tests in subjects with IDDM. RESEARCH DESIGN AND METHODS: Seventy-six subjects with IDDM of < 10 years duration had cardiovascular autonomic reflex tests and were evaluated for signs and symptoms of AN. RESULTS: Fifty-seven subjects (66%) were available for restudy 9 years later (15 had died, 4 could not be located). Of the symptoms of AN, only gastroparesis increased in prevalence (P < 0.01). Of the five cardiovascular AN measures, only the R-R response to the Valsalva maneuver deteriorated (F[1,44] = 10.61, P < 0.01). CONCLUSIONS: The progression of AN in IDDM is monitored best longitudinally by the Valsalva maneuver because of the small variance ratio in repeated measures. Prevalence rates can be monitored by expiration-to-inspiration R-R or Valsalva ratios. Most clinical signs and symptoms of AN do not progress, underscoring the need for objective and quantitative autonomic function tests to identify people at risk for premature death.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF]

				V Bansal, J Kalita, and U K Misra Diabetic neuropathy Postgrad. Med. J., February 1, 2006; 82(964): 95 - 100. [Abstract] [Full Text] [PDF]

				A. I. Vinik, D. Anandacoomaraswamy, and J. Ullal Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins? Diabetes Care, August 1, 2005; 28(8): 2067 - 2072. [Full Text] [PDF]

				M. S. Faulkner, L. Quinn, J. H. Rimmer, and B. H. Rich Cardiovascular Endurance and Heart Rate Variability in Adolescents With Type 1 or Type 2 Diabetes Biol Res Nurs, July 1, 2005; 7(1): 16 - 29. [Abstract] [PDF]

				E. B. Schroeder, L. E. Chambless, D. Liao, R. J. Prineas, G. W. Evans, W. D. Rosamond, and G. Heiss Diabetes, Glucose, Insulin, and Heart Rate Variability: The Atherosclerosis Risk in Communities (ARIC) study Diabetes Care, March 1, 2005; 28(3): 668 - 674. [Abstract] [Full Text] [PDF]

				S. T.M. Krishnan and G. Rayman The LDIflare: A novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes Diabetes Care, December 1, 2004; 27(12): 2930 - 2935. [Abstract] [Full Text] [PDF]

				R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes: A meta-analysis Diabetes Care, June 1, 2003; 26(6): 1895 - 1901. [Abstract] [Full Text] [PDF]

				A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman Diabetic Autonomic Neuropathy Diabetes Care, May 1, 2003; 26(5): 1553 - 1579. [Abstract] [Full Text] [PDF]

				M. Kirby Painful diabetic neuropathy -- current understanding and management for the primary care team The British Journal of Diabetes & Vascular Disease, March 1, 2003; 3(2): 138 - 144. [Abstract] [PDF]

				Z. T. Bloomgarden The American Diabetes Association's 48th Annual Advanced Postgraduate Course Diabetes Care, August 1, 2001; 24(8): 1489 - 1495. [Full Text] [PDF]